Valuation: Edwards Lifesciences Corporation

Market Cap 52.38B 44.88B 42.06B 38.42B 72.5B 4,993B 73.21B 496B 193B 2,519B 197B 192B 8,343B P/E 2026 *
35.9x
P/E 2027 * 27.5x
Enterprise Value 48.75B 41.77B 39.14B 35.75B 67.47B 4,647B 68.14B 462B 180B 2,345B 183B 179B 7,765B EV / Sales 2026 *
7.21x
EV / Sales 2027 * 6.35x
Free-Float
86.96%
Yield 2026 *
-
Yield 2027 * -
1 day+0.41%
1 week-0.12%
Current month+5.58%
1 month+9.97%
3 months+5.93%
6 months+8.96%
Current year+6.59%
1 week 88.79
Extreme 88.79
92.27
1 month 81.16
Extreme 81.155
93.91
Current year 74.66
Extreme 74.66
96.29
1 year 72.3
Extreme 72.3
96.29
3 years 58.93
Extreme 58.93
96.29
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 11/05/2023
Director of Finance/CFO 43 29/05/2026
Chief Tech/Sci/R&D Officer 51 01/09/2025
Director TitleAgeSince
Chairman 69 07/05/2024
Director/Board Member 62 10/02/2015
Director/Board Member 58 11/05/2023
Date Insider Type Main position Quantity % Market Cap.
11/8/26 Fiscal year

Executive/Senior Manager

1,857 0.0003%
30/7/26 Sell

Executive/Senior Manager

-146 0.0000%
28/7/26 Fiscal year

Executive/Senior Manager

28,884 0.0050%
Change 5-day change 1-year change 3-year change Capi.($)
+0.41%-0.12%+12.38%+19.30% 52.38B
-0.09%+6.64%+28.00%+15.98% 232B
+0.40%+8.21%+3.97%-15.48% 152B
-0.46%-4.94%-20.62%+24.97% 131B
+1.73%-1.21%-52.56%-1.77% 72.26B
-0.38%-1.00%-16.22%-13.49% 51.57B
+0.87%+4.26%+29.90%+29.32% 43.71B
+0.90%+3.29%+38.63%+51.60% 40.72B
+0.79%+19.49%+125.76%+42.33% 33.97B
+1.78%+7.55%-17.22%+46.97% 34.13B
Average +0.49%+4.06%+13.20%+19.97% 84.42B
Weighted average by Cap. +0.30%+3.79%+8.26%+13.33%

Financials

2026 *2027 *
Net sales 6.76B 5.79B 5.43B 4.96B 9.36B 644B 9.45B 64.02B 24.92B 325B 25.38B 24.83B 1,077B 7.43B 6.37B 5.97B 5.45B 10.28B 708B 10.38B 70.36B 27.39B 357B 27.89B 27.29B 1,183B
Net income 1.44B 1.23B 1.15B 1.05B 1.99B 137B 2.01B 13.59B 5.29B 69.03B 5.39B 5.27B 229B 1.9B 1.63B 1.52B 1.39B 2.63B 181B 2.65B 17.96B 6.99B 91.23B 7.12B 6.97B 302B
Net Debt -3.63B -3.11B -2.92B -2.66B -5.03B -346B -5.08B -34.39B -13.39B -175B -13.63B -13.34B -578B -5.19B -4.45B -4.17B -3.81B -7.19B -495B -7.26B -49.2B -19.15B -250B -19.5B -19.08B -827B
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
25/08/26 US$90.87 +0.41% 2,389,753
24/08/26 US$90.50 +0.79% 2,722,012
21/08/26 US$89.79 -0.04% 2,819,775
20/08/26 US$89.83 -2.65% 2,638,021
19/08/26 US$92.28 +1.43% 3,406,151
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
90.87USD
Average target price
100.96USD
Spread / Average Target
+11.11%

Quarterly revenue - Rate of surprise